Development of a bedside scoring tool to diagnose biliary atresia in infants with neonatal cholestasis
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2024 - 65535
Project Lead
Authors
Kaithon Jay Cheriyan, Lea Varghese, Devesh Bhaskar Yerrapragada, Srinivas Rajkiran Raju, Jainy N J, Smitha Joseph, Ranjini Srinivasan.
Project Status
ongoing